Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | FLT4 | P35916 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | NAMPT | P43490 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3428561 | 0.84 | NPC1 (0.44) | SMN1; SMN2RAB9ANPC1GAA | |
| SCHEMBL5472894 | 0.84 | L3MBTL1 (0.36) | CDK2FLT4KMT2AMEN1L3MBTL1 | |
| SCHEMBL3430577 | 0.79 | SMN1; SMN2 (0.55) | CDK2FLT4L3MBTL1SMN1; SMN2HTT | |
| SCHEMBL5478772 | 0.78 | ALDH1A1 (0.46) | KMT2ASMN1; SMN2HTTRAB9ANPC1 | |
| SCHEMBL5476348 | 0.76 | POLB (0.34) | KMT2AMEN1SMN1; SMN2HTTRAB9A | |
| SCHEMBL1903812 | 0.75 | SMN1; SMN2 (0.57) | CDK2KMT2AMEN1SMN1; SMN2HTT | |
| SCHEMBL1906809 | 0.74 | HSD17B10 (0.41) | KMT2AMEN1L3MBTL1SMN1; SMN2HTT | |
| SCHEMBL5481218 | 0.74 | GAA (0.36) | KMT2AMEN1NPC1GAA | |
| SCHEMBL12468731 | 0.73 | SMN1; SMN2 (0.41) | KMT2AMEN1SMN1; SMN2HTTRAB9A | |
| SCHEMBL8918118 | 0.73 | LMNA (0.34) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070208021-A1 | Phenoxyacetic Acid Derivatives and Drug Comprising The Same | DAIICHI PHARMACEUTICAL CO., LTD. | 2007-09-06 | — | — | US | disclosed |
| EP-1731513-A1 | PHENOXYACETIC ACID DERIVATIVE AND MEDICINE CONTAINING THE SAME | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208021-A1 | Phenoxyacetic Acid Derivatives and Drug Comprising The Same | PPARA, PPARG, PPARD | CDK2 2043/4885FLT4 1539/4885KMT2A 1816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.